Zhuhai Boaizhiguang Technology

The company's business revolves around its role as the exclusive mainland China distributor for the 'DISC' soft hydrophilic contact lens, a product developed from 18 years of research at Hong Kong Polytechnic University (PolyU). This strategic cooperation with PolyU, established in 2018, positions DISC-Eye at the forefront of myopia management technology. The business model is centered on distributing these specialized lenses through a network of authorized hospitals and medical service-qualified optometry centers, explicitly avoiding online or non-medical retail channels to ensure professional fitting and aftercare. This strategy targets individuals, particularly children and adolescents, seeking effective solutions for myopia progression.

The core product, the DISC (Defocus Incorporated Soft Contact) lens, utilizes 'multi-ring defocus' technology to shift peripheral light focus in front of the retina, which is believed to control the elongation of the eyeball and thereby slow down the progression of nearsightedness. Clinical trials have demonstrated significant efficacy, with one multi-center study showing a 59.35% reduction in myopia progression and a 55.10% control of eye-axis elongation with consistent daily wear. The results were even more pronounced in children under nine, reaching a 71.43% myopia control rate. In December 2022, the company secured a significant Series A funding round of nearly 100 million CNY from LYFE Capital, a private equity firm. This capital injection is earmarked for talent acquisition, further clinical trials, product development, and commercial expansion.